His Excellency Sheikh Nahyan, Minister of Tolerance, today officially inaugurated CPhI Middle East & Africa 2019, the region’s leading platform for the pharmaceutical industry followed by a tour of the exhibition and introducing the keynote session.
The event, which is returning for a second year after its successful launch in the capital last year and sponsored by the Ministry of Health and Protection (MoHaP), will take place at the Abu Dhabi National Exhibition Centre (ADNEC) from 16-18 September 2019. The event is providing a showcase for over 294 exhibitors and is expecting to attract 4,900+ visitors.
The onsite conference programme opened with a keynote speech from His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary of Public Health Policy & Licensing Sector in UAE Ministry of Health & Prevention, MoHaP. Entitled Healthcare and Pharmaceutical Continuum: Highlights Across the Region, where he addressed a number of topics including a focus on Middle East healthcare systems, creating value for patients and society, R&D investments and an overview on creating a smart regulatory environment for the UAE.
According to research commissioned by CPhI, the pharma market in the MENA region is set to top US$41 billion by 2022 while also increasing partnership and business opportunities at both a local and international and to further increase the value of the market in this region.
A total of 14 sessions are scheduled for the three-day showcase, including on day one An Industry Players Perspective on Pharma Manufacturing in the GCC, The Forgotten
CPhI MEA takes place from 16-18 September, for further information please visit www.cphi.com/mea.
